Avon, OH, United States of America

Kwok Peng Ng

This inventor holds 2 USPTO granted patents. Top assignee: The Cleveland Clinic Foundation. Active years: 2018-2019.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Kwok Peng Ng. Retrieved from https://idiyas.com/inventor/kwok-peng-ng

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1

Forward Citations = 3(Granted Patents)


Company Filing History:


Years Active: 2018-2019

Loading Chart...
2 patents (USPTO):Explore Patents

Title: Kwok Peng Ng: Innovator in Antitumor Therapy

Introduction

Kwok Peng Ng is a notable inventor based in Avon, OH (US). He has made significant contributions to the field of antitumor therapy, holding 2 patents to his name. His work focuses on developing innovative solutions for cancer treatment.

Latest Patents

Among his latest patents, he has developed antitumor derivatives for differentiation therapy. Specifically, he has described imidazopyridine derivatives according to a specific formula, which are aimed at enhancing therapeutic outcomes in cancer treatment.

Career Highlights

Kwok Peng Ng is associated with The Cleveland Clinic Foundation, a prestigious institution known for its commitment to medical research and innovation. His work at this institution has allowed him to explore and develop groundbreaking therapies that have the potential to change the landscape of cancer treatment.

Collaborations

He has collaborated with esteemed colleagues, including Yogenthiran Saunthararajah and James G Phillips. These collaborations have fostered a productive environment for research and innovation in the field of antitumor therapies.

Conclusion

Kwok Peng Ng's contributions to antitumor therapy through his patents and collaborations highlight his dedication to advancing medical science. His work continues to inspire future innovations in cancer treatment.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…